Navigation Links
Garlic compound may help treat cancer

Two Indian scientists have developed a new method that advocates the use of a garlic component to treat cancer-causing tumours// .

D. Karunagaran, a professor at the department of biotechnology at the Indian Institute of Technology (IIT) in Madras, and Suby Oommen, a PhD student at the Rajiv Gandhi Centre for Biotechnology in Kerala, have been working on garlic-based components and their effects on cancer cells from 1998.

The researchers said the novel treatment involves a synergistic composition comprising a garlic organosulphur compound Diallyl trisulfide (DATS) and an anti-cancer agent.

DATS, a constituent of garlic, is one of a group of substances that contain sulphur and anti-cancer agent is a substance that prevents, kills or blocks the growth or spread of cancer cells.

DATS acts synergistically with taxol-most commonly used anti-cancer agent to treat ovarian, breast and non-small cell lung cancers.

The treatment option given is a combination of taxol and DATS, Karunagaran told IANS in an Internet interview.

Although this idea is not new, the application of this idea to this set of compounds is new.

The inventors have filed a patent for their invention. Once granted the patent will be in the name of Kerala's Rajiv Gandhi Centre for Biotechnology where the work was carried out.

"Our findings are mainly at the laboratory level and we really have no clue as to how effective this will be at the patient level. But then this is how everything begins at the initial stages," Karunagaran said.

Garlic (Allium sativum), a member of the Allium family, is one of the earliest documented plants for its manifold uses. Authoritative texts of ancient times endorse its usage not only in the medicine chest but also for religious purposes, Karunagaran said.

The knowledge of its beneficiary effects found its usage span across all the major ancient civilizations. < br>
Egyptians, Greeks, Chinese and Indians used garlic for centuries for treating various ailments such as heart disease, arthritis, pulmonary complaints, abdominal growths (particularly uterine) and worm infestation. It was in 1958 that its anti-tumour properties were clearly documented.

Garlic has more than 30 different organosulphur compounds. Many of these can inhibit the proliferation whereas some of them can induce apoptosis (a form of programmed cell death) in cancer cells, Karunagaran said.

The main clue from the present invention is that a composition comprising a garlic organosulphur compound together with an anti-cancer agent may work well for treatment of tumors, he said.

However, these data are mainly based on in vitro studies and extending them to the patient level takes time and should involve further studies including human clinical trials, he said.

Source-IANS
'"/>




Related medicine news :

1. More to Garlic than warding of Dracula
2. Garlic a day keeps cancer away
3. Garlic fights malaria and cancer
4. Garlic Supplements Impede HIV Therapy
5. Vegetables And Garlic Confer Protection From Skin Cancer
6. Another Feather In The Garlic Cap: Helpful In Avoiding Breast Cancer
7. Garlic inhibits fungal growth and protects food
8. Garlic Helps To Reduce Cholesterol in Rats
9. New Garlic Product Mimics Garlic to Perfection
10. Onions, Garlic may Reduce the Risk of Cancer
11. Garlic may Not Aid in Heart Disease and Cholesterol Levels
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... Phytomer USA ... As a Phytomer Account Manager, Smith’s role is to provide excellent customer ... that make up The Phytomer Group. Smith comes to Phytomer with a wealth of ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of New Jersey ... “A” and its outlook as “stable.” At the same time, the ratings agency cautioned ... recent years, dip below “capital adequacy” thresholds required for its strong rating. , “Horizon ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... liability could substantially improve drug safety and minimize the cost of development. In ... ion channel inhibition using cell lines and for cardiac toxicity using induced pluripotent ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: